Your English writing platform
Discover LudwigExact(12)
On the other hand, a localized ovarian tumour in a BRCA2 mutation carrier is presented in Fig. 3.
The lifetime risk of developing PAH in a BMPR2 mutation carrier is less than 20%[ 4].
94 The optimal timing of prophylactic surgery for an asymptomatic BRCA mutation carrier is highly personal.
The ability to predict whether a BRCA1 mutation carrier is likely to develop malignant disease early or late in life would facilitate the clinical management of these patients.
Once an unaffected mutation carrier is identified, the question becomes what is the likelihood that she will develop cancer by a given age (age-specific penetrance).
It is also possible that no breast cancer that develops in a BRCA1 mutation carrier is really 'incidental' or sporadic, even if LOH of wt BRCA1 does not exist.
Similar(48)
At least one mutation carrier was found in 112 prostate cancer families (4.6 %), all of European descent.
The controls had to have been alive when their matched mutation carrier was diagnosed.
For example, if a mutation carrier was born on June 30 , 1996 this would translate to 1996.5.
No mutation carrier was found among 118 unselected Jewish individuals of Iranian origin.
In the present study, no mutation carrier was discovered among the 190 patients with borderline tumours.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com